This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1994 Aug;33(8):787.

doi: 10.1093/rheumatology/33.8.787.

Systemic lupus erythematosus following interferon therapy

A Flores, A Olivé, E Feliu, X Tena

PMID: 8055211
DOI: 10.1093/rheumatology/33.8.787

Case Reports

Systemic lupus erythematosus following interferon therapy

A Flores et al. Br J Rheumatol. 1994 Aug.

. 1994 Aug;33(8):787.

doi: 10.1093/rheumatology/33.8.787.

Authors

A Flores, A Olivé, E Feliu, X Tena

PMID: 8055211
DOI: 10.1093/rheumatology/33.8.787

No abstract available

PubMed Disclaimer

Similar articles

Development of chorea with lupus anticoagulant after interferon therapy.
Neau JP, Guilhot F, Boinot C, Dumas P, Tantot AM, Gil R. Neau JP, et al. Eur Neurol. 1996;36(4):235-6. doi: 10.1159/000117257. Eur Neurol. 1996. PMID: 8814429 No abstract available.
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia.
Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M. Schilling PJ, et al. Cancer. 1991 Oct 1;68(7):1536-7. doi: 10.1002/1097-0142(19911001)68:7<1536::aid-cncr2820680713>3.0.co;2-b. Cancer. 1991. PMID: 1893353
35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy.
Mehta ND, Hooberman AL, Vokes EE, Neeley S, Cotler S. Mehta ND, et al. Am J Hematol. 1992 Oct;41(2):141. doi: 10.1002/ajh.2830410215. Am J Hematol. 1992. PMID: 1415177 No abstract available.
Role of interferon-alpha in chronic myeloid leukemia.
Kumar L, Basade M, Gulati SC. Kumar L, et al. J Assoc Physicians India. 1995;Suppl 3:26-32. J Assoc Physicians India. 1995. PMID: 8773119 Review. No abstract available.
[Chronic myelogenous leukemia].
Urabe A. Urabe A. Nihon Rinsho. 2006 Jul;64(7):1286-90. Nihon Rinsho. 2006. PMID: 16838646 Review. Japanese.

See all similar articles

Cited by

Tolerability of treatments for viral hepatitis.
Gervais A, Boyer N, Marcellin P. Gervais A, et al. Drug Saf. 2001;24(5):375-84. doi: 10.2165/00002018-200124050-00004. Drug Saf. 2001. PMID: 11419564 Review.
Cytokine-induced autoimmune disorders.
Miossec P. Miossec P. Drug Saf. 1997 Aug;17(2):93-104. doi: 10.2165/00002018-199717020-00002. Drug Saf. 1997. PMID: 9285200 Review.
Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies.
Ali Khan W. Ali Khan W. Cent Eur J Immunol. 2018;43(1):58-68. doi: 10.5114/ceji.2018.74874. Epub 2018 Mar 30. Cent Eur J Immunol. 2018. PMID: 29736147 Free PMC article.
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.
Niewold TB, Swedler WI. Niewold TB, et al. Clin Rheumatol. 2005 Apr;24(2):178-81. doi: 10.1007/s10067-004-1024-2. Epub 2004 Nov 24. Clin Rheumatol. 2005. PMID: 15565395 Review.
Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.
Chou SM, Yeh HJ, Lin TM, Chang YS, Hsu HC, Shen YC, Kuo TT, Chen JH, Chen SC, Chang CC. Chou SM, et al. Front Immunol. 2022 Oct 7;13:992819. doi: 10.3389/fimmu.2022.992819. eCollection 2022. Front Immunol. 2022. PMID: 36275719 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information